Patient Recruitment and Retention

We often refer to participants as the heroes of research. Clinical trials and the medical advances made through research don’t happen without them. But here comes the holidays – will your study participant compliance waver during these busy times? Patient recruitment, retention, and compliance with…

The 2023 Global Site Solutions Summit successfully brought clinical trial sites, sponsors, CROs, and vendors together to express concerns and develop comprehensive solutions. Like most of you, I’ve attended many conferences related to the clinical trial industry. Some would say too many! But anyone expecting…

Clinical trial recruitment and patient engagement practices have evolved and so has clinical trial technology. What does the future look like? I recently spoke with Matthew Stumm, founder and president of the Boston-based patient recruitment agency Stark / Raving Health. I’ve known Matt for many…

Participant retention in clinical trials is key to the success of any study. I have mentioned in a few previous blog posts that I am a huge fan of thanking patients. This means acknowledging in some way the site’s and sponsor’s appreciation for their commitment…

Getting a drug from the bench to the bedside takes around 10-15 years and around 6-7 of those years are spent in clinical trials. While it’s difficult to determine the exact amount, the cost of drug development appears to range from less than $1 billion to…

This year, I reached a milestone I was never expected to achieve. June 11 marked my 10-year “cancerversary” – the anniversary of my cancer diagnosis, the date of the first of many surgeries, and the date that my world changed completely in just a few…

This is the last in my three-part series revealing hidden causes behind delays in clinical studies. Part one is here, and part two is here. This final installment explores clinical trial retention and compliance. Are you waiting too long to begin planning patient retention and…

Imperial’s team attended the annual SCOPE Summit in Orlando, where they spoke with hundreds of clinical trials industry colleagues and attended talks and workshops. In this post, Imperial team members Dan McDonald, Imogen Cheese, and Ted Corrigan tell us what they found noteworthy at SCOPE.…

This is the second in my three-part series revealing hidden causes behind delays in clinical studies. The first part is here. This installment explores strategies to meet clinical trial enrollment goals. Tell me when your first patient was enrolled, and I will tell you the…